We show here that β1 integrins selectively modulate insulin-like growth factor type I receptor (IGF-IR) signaling in response to IGF stimulation. The β1A integrin forms a complex with the IGF-IR and insulin receptor substrate-1 (IRS-1); this complex does not promote IGF-I mediated cell adhesion to laminin (LN), although it does support IGF-mediated cell proliferation. In contrast, β1C, an integrin cytoplasmic variant, increases cell adhesion to LN in response to IGF-I and its down-regulation by a ribozyme prevents IGF-mediated adhesion to LN. Moreover, β1C completely prevents IGF-mediated cell proliferation and tumor growth by inhibiting IGF-IR auto-phosphorylation in response to IGF-I stimulation. Evidence is provided that the β1 cytodomain plays an important role in mediating β1 integrin association with either IRS-1 or Grb2-associated binder1 (Gab1)/SH2-containing protein-tyrosine phosphate 2 (Shp2), downstream effectors of IGF-IR: specifically, β1A associates with IRS-1 and β1C with Gab1/Shp2. This study unravels a novel mechanism mediated by the integrin cytoplasmic domain that differentially regulates cell adhesion to LN and cell proliferation in response to IGF.
Skip Nav Destination
Article navigation
2 August 2004
Article|
August 02 2004
Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins
Hira Lal Goel,
Hira Lal Goel
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Mara Fornaro,
Mara Fornaro
4Department of Pathology, Yale University School of Medicine, New Haven, CT 06510
Search for other works by this author on:
Loredana Moro,
Loredana Moro
4Department of Pathology, Yale University School of Medicine, New Haven, CT 06510
Search for other works by this author on:
Natalia Teider,
Natalia Teider
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Johng S. Rhim,
Johng S. Rhim
5Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814
Search for other works by this author on:
Michael King,
Michael King
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Lucia R. Languino
Lucia R. Languino
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
2Department Cell Biology, University of Massachusetts Medical School, Worcester, MA 01605
3Cancer Center, University of Massachusetts Medical School, Worcester, MA 01605
4Department of Pathology, Yale University School of Medicine, New Haven, CT 06510
Search for other works by this author on:
Hira Lal Goel
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
Mara Fornaro
4Department of Pathology, Yale University School of Medicine, New Haven, CT 06510
Loredana Moro
4Department of Pathology, Yale University School of Medicine, New Haven, CT 06510
Natalia Teider
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
Johng S. Rhim
5Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814
Michael King
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
Lucia R. Languino
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605
2Department Cell Biology, University of Massachusetts Medical School, Worcester, MA 01605
3Cancer Center, University of Massachusetts Medical School, Worcester, MA 01605
4Department of Pathology, Yale University School of Medicine, New Haven, CT 06510
Address correspondence to Lucia Languino, Dept. of Cancer Biology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 01605. Tel.: (508) 856-1606. Fax: (508) 856-3845. email: [email protected]
Abbreviations used in this paper: β-gal, β-galactosidase; FN, fibronectin; Gab1, Grb2-associated binder1; IGF, insulin-like growth factor; IGF-IR, IGF type 1 receptor; IRS-1, insulin receptor substrate-1; LN, laminin; PI 3-kinase, phosphatidylinositol 3-kinase; RZ, ribozyme; Shp2, SH2-containing protein-tyrosine phosphatase 2; SRB, Sulforhodamine B; tet, tetracycline.
Received:
March 01 2004
Accepted:
June 14 2004
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2004
J Cell Biol (2004) 166 (3): 407–418.
Article history
Received:
March 01 2004
Accepted:
June 14 2004
Connected Content
This article has been corrected
Correction: Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins
Citation
Hira Lal Goel, Mara Fornaro, Loredana Moro, Natalia Teider, Johng S. Rhim, Michael King, Lucia R. Languino; Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins . J Cell Biol 2 August 2004; 166 (3): 407–418. doi: https://doi.org/10.1083/jcb.200403003
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement